Alzheimer's Disease Neurodegenerative Diseases Cognitive Disorders Stroke Treatment Epilepsy Brain Health Stroke Management Stroke Dementia Care Diagnosis Neurological Disorders Brain Diseases Brain Injuries Parkinson's Disease Dementia Patient Experiences Brain Disorders Corticobasal Degeneration Brain Health Assessment Immunotherapy ALS (Amyotrophic Lateral Sclerosis) Behavioral Sciences Research Cerebral Small Vessel Disease Sleep Medicine Dementia Research Epidemiology Nerve Stimulation Pain Management Symptoms Research Initiatives Cognitive Assessment Neurodegenerative Disorders Cognitive Impairment Headache Disorders Vestibular Disorders Cerebral Aneurysm Neurogenesis Rare Diseases Brain Tumors Seizure Disorders Neurological Diseases Epilepsy Treatment Neurodegenerative Conditions Brain Scans Neuroinflammation Neural Control Cholesterol Stroke Care Consultation Seizures Cognitive Decline Amyotrophic Lateral Sclerosis Rare neurological conditions Brain Injury Prognosis
The evidence rests on indirect molecular markers from a small postmortem cohort, drawing pushback from some neurogenesis researchers.
